In this report, we share the impact of the diagnosis and challenges during the clinical management of two brothers with CMMRD from a non-consanguineous family harboring compound heterozygous variants in the PMS2 gene, who presented with different phenotypic manifestations and cancer spectrum. This evidence concerns the gene PMS2 and cancer.